Polyamines drive myeloid cell survival by buffering intracellular pH to promote immunosuppression in glioblastoma
Open Access
- 19 February 2021
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (8), eabc8929
- https://doi.org/10.1126/sciadv.abc8929
Abstract
Glioblastoma is characterized by the robust infiltration of immunosuppressive tumor-associated myeloid cells (TAMCs). It is not fully understood how TAMCs survive in the acidic tumor microenvironment to cause immunosuppression in glioblastoma. Metabolic and RNA-seq analysis of TAMCs revealed that the arginine-ornithine-polyamine axis is up-regulated in glioblastoma TAMCs but not in tumor-infiltrating CD8+ T cells. Active de novo synthesis of highly basic polyamines within TAMCs efficiently buffered low intracellular pH to support the survival of these immunosuppressive cells in the harsh acidic environment of solid tumors. Administration of difluoromethylornithine (DFMO), a clinically approved inhibitor of polyamine generation, enhanced animal survival in immunocompetent mice by causing a tumor-specific reduction of polyamines and decreased intracellular pH in TAMCs. DFMO combination with immunotherapy or radiotherapy further enhanced animal survival. These findings indicate that polyamines are used by glioblastoma TAMCs to maintain normal intracellular pH and cell survival and thus promote immunosuppression during tumor evolution.Keywords
Funding Information
- National Cancer Institute (R35CA197532)
- National Cancer Institute (P50CA221747)
- National Institute of Neurological Disorders and Stroke (R01NS093903)
- National Institute of Neurological Disorders and Stroke (1R01NS115955-01)
This publication has 76 references indexed in Scilit:
- Depletion of cellular polyamines, spermidine and spermine, causes a total arrest in translation and growth in mammalian cellsProceedings of the National Academy of Sciences of the United States of America, 2013
- Involvement of tumor acidification in brain cancer pathophysiologyFrontiers in Physiology, 2013
- Modulation of Microenvironment Acidity Reverses Anergy in Human and Murine Tumor-Infiltrating T LymphocytesCancer Research, 2012
- Macrophage Expression of Hypoxia-Inducible Factor-1α Suppresses T-Cell Function and Promotes Tumor ProgressionCancer Research, 2010
- HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironmentThe Journal of Experimental Medicine, 2010
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunityThe Journal of Experimental Medicine, 2010
- The Role of Carbonic Anhydrase 9 in Regulating Extracellular and Intracellular pH in Three-dimensional Tumor Cell GrowthsOnline Journal of Public Health Informatics, 2009
- Identification of an alternatively spliced isoform of carbonic anhydrase XII in diffusely infiltrating astrocytic gliomasNeuro-Oncology, 2008
- Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancerNature Medicine, 2007
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaThe New England Journal of Medicine, 2005